Jubilant Radiopharma recently invested $50 million (USD) to expand its PET radiopharmaceutical manufacturing facilities within its Radiopharmacies Division. Harsher Singh, President, further explains, "I see the future of Jubilant Radiopharma as a full-service company offering novel products, services and distribution networks that rival no other and position our mission of Improving Lives through Nuclear Medicine™ well into the future." For more information, please visit https://lnkd.in/gTmrNH6n #JubilantRadiopharma #NuclearMedicine #CardiacPETImaging #DiagnosticImaging
Jubilant Radiopharma
Pharmaceutical Manufacturing
Yardley, PA 19,752 followers
Improving Lives Through Nuclear Medicine
About us
Jubilant Radiopharma is an industry leading pharmaceutical company specializing in nuclear medicine focused on developing, manufacturing, commercializing and distributing high quality and sustainable diagnostic and therapeutic agents for the sole purpose of Improving Lives Through Nuclear Medicine on a global scale.
- Website
-
http://www.jubilantradiopharma.com
External link for Jubilant Radiopharma
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Yardley, PA
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Nuclear Medicine, Radiopharmacy, and Cardiac PET
Locations
-
Primary
790 Township Line Rd
Suite 175
Yardley, PA 19067, US
Employees at Jubilant Radiopharma
Updates
-
We are pleased to welcome this year’s talented intern cohort. Supporting various functions of the company, these sharp minds deliver unique perspectives and valuable expertise. We are committed to contributing and shaping their professional development throughout their internship. Thank you for including us in your journey! Nous avons le plaisir d'accueillir la cohorte de stagiaires talentueux de cette année. Soutenant différents départements de l'entreprise, ces esprits agiles apportent des perspectives uniques et une expertise précieuse. Nous nous engageons à contribuer à leur développement professionnel tout au long de leur stage. Merci de nous intégrer dans votre parcours! #JubliantRadiopharma
-
Jubilant Radiopharma reposted this
Jubilant Radiopharma would like to wish all of our colleagues, customers and partners in the U.S. a safe and happy Fourth of July! #JubliantRadiopharma #IndependenceDay #FourthofJuly #DiagnosticImaging #NuclearMedicine
-
Jubilant Radiopharma would like to wish all of our colleagues, customers and partners in the U.S. a safe and happy Fourth of July! #JubliantRadiopharma #IndependenceDay #FourthofJuly #DiagnosticImaging #NuclearMedicine
-
Today Jubilant Radiopharma wishes our Canadian colleagues, customers, and partners a Happy Canada Day. #CanadaDay2024 #JubilantRadiopharma #NuclearMedicine #ImprovingLivesThroughNuclearMedicine
-
Another successful SNMMI is in the books for Jubilant Radiopharma! Thank you to all of our customers and partners for stopping by, visiting with us and supporting our products and services. It was truly a pleasure seeing you all, and we look forward to seeing you in New Orleans in 2025. #2024SNMMI #NucelarMedicine #DiagnosticImaging #ImprovingLivesThroughNuclearMedicne
-
Territory Sales Specialist (Tennessee, North Carolina, South Carolina, Alabama) This position may be based in Nashville/Memphis (TN) or Charlotte (NC) Join us: https://lnkd.in/e9dcdpK8
-
We look forward to seeing you all at the Society of Nuclear Medicine and Molecular Imaging annual meeting next week in Toronto. Stop by booth #517, and see how Jubilant Radiopharma is "Improving Lives through Nuclear Medicine™.” #NuclearMedicine #DiagnosticImaging #SNMMI2024 #CardiacImaging #NuclearRadiopharmacies #ImprovingLivesThroughNuclearMedicine
-
Please join us in welcoming Harsher Singh to the Jubilant Radiopharma family, as our newly appointed CEO. With a proven track record in the biopharmaceutical industry, Harsher brings valuable expertise to lead our radiopharmaceutical division. His strategic vision and commitment to innovation align perfectly with our mission to provide cutting-edge solutions in nuclear medicine and molecular imaging. We look forward to working with Harsher to continue to make a positive impact on patients’ lives through groundbreaking radiopharmaceuticals. ~~ Nous sommes ravis d’annoncer la nomination de Harsher Singh au poste de président-directeur général de Jubilant Radiopharma. En plus de son expérience reconnue dans l’industrie biopharmaceutique, Harsher apporte une expertise précieuse pour la direction de notre division radiopharmaceutique. Sa vision stratégique et son engagement envers l’innovation reflètent parfaitement notre mission d’offrir des solutions de pointe en médecine nucléaire et en imagerie moléculaire. Joignez-vous à nous pour souhaiter la bienvenue à Harsher Singh au sein de la famille Jubilant Radiopharma. Ensemble, nous poursuivons notre impact positif sur la vie des patients grâce à nos produits radiopharmaceutiques révolutionnaires.